Synergistic up-regulation of vascular endothelial growth factor expression in murine macrophages by adenosine A2A receptor agonists and endotoxin

American Journal of Pathology

Volumn 160, Issue 6, 2002, Pages 2231-2244

  Leibovich, Samuel Joseph ^a   Chen, Jiang Fan ^b   Pinhal Enfield, Grace ^a   Belem, Paula C ^a   Elson, Genie ^a   Rosania, Anthony ^a   Ramanathan, Madhuri ^a   Montesinos, Carmen ^c   Jacobson, Marlene ^d   Schwarzschild, Michael A ^b   Fink, J Stephen ^b   Cronstein, Bruce ^c  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

^c NEW YORK UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 CHLORO 6 N CYCLOPENTYLADENOSINE; 2 [4 (2 CARBOXYETHYL)PHENETHYLAMINO]ADENOSINE 5' (N ETHYLCARBOXAMIDE); 3,7 DIMETHYL 1 PROPARGYLXANTHINE; 4 [2 [7 AMINO 2 (2 FURYL) 1,2,4 TRIAZOLO[2,3 A][1,3,5]TRIAZIN 5 YLAMINO]ETHYL]PHENOL; 8 CYCLOPENTYL 1,3 DIPROPYLXANTHINE; ADENOSINE; ADENOSINE 5' (N ETHYLCARBOXAMIDE); ADENOSINE A1 RECEPTOR ANTAGONIST; ADENOSINE A2 RECEPTOR ANTAGONIST; ADENOSINE A2A RECEPTOR; ADENOSINE A2A RECEPTOR AGONIST; ENDOTOXIN; GAMMA INTERFERON; LIPOPOLYSACCHARIDE; NITRIC OXIDE SYNTHASE; VASCULOTROPIN;

ANIMAL CELL; ARTICLE; BIOASSAY; CELL VIABILITY; CORNEA; HYPOXIC CELL; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SIGNAL TRANSDUCTION; WESTERN BLOTTING;

EID: 0036087180     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)61170-4     Document Type: Article

References (67)

1. Production of vascular endothelial growth factor by murine macrophages
2. Vascular endothelial growth factor mediates angiogenic activity during the proliferative phase of wound healing
3. Vascular endothelial growth factor is essential for corpus luteum angiogenesis
4. Vascular endothelial growth factor production in peritoneal macrophages of cirrhotic patients: Regulation by cytokines and bacterial lipopolysaccharide
5. Lactate elicits vascular endothelial growth factor from macrophages: A possible alternative to hypoxia
6. Formation and release of purine catabolites during hypoperfusion, anoxia and ischemia
7. Interstitial transudate purines in normoxic and hypoxic immature and mature rabbit hearts
8. Signal transduction via P2-purinergic receptors for extracellular ATP and other nucleotides
9. Urokinase receptor antagonists inhibit angiogenesis and primary tumor growth in syngeneic mice
10. Human mononuclear phagocytes express adenosine A1 receptors
11. 2B adenosine receptor expression in macrophages: A mechanism of macrophage deactivation
12. Adenosine receptors and modulation of natural killer cell activity by purine nucleosides
13. Adenosine increases interleukin 6 release and decreases tumor necrosis factor release from rat adrenal zona glomerulosa cells, ovarian cells, anterior pituitary cells, and peritoneal macrophages
14. Adenosine enhances IL-10 secretion by human monocytes
15. 2A receptor-dependent and independent mechanisms
16. Nomenclature and classification of purinoreceptors
17. Receptors for adenine nucleotides: Subclassification, distribution, and molecular characterization
18. Cloning and expression of an A1 adenosine receptor from rat brain
19. Selective amplification and cloning of four new members of the G-protein-coupled receptor family
20. 2-adenosine receptor subtype
21. 3 adenosine receptor
22. Adenosine, an endogenous anti-inflammatory agent
23. 2 receptors?
24. 5′-N-ethylcarboxamidoadenosine-a potent inhibitor of human platelet aggregation
25. 2 receptors in rat brain
26. Suppression of inflammatory protein (MIP)-1 alpha production and collagen-induced arthritis by adenosine receptor agonists
27. Adenosine and a related carbocyclic nucleoside analogue selectively inhibit tumor necrosis factor-a production and protect mice against endotoxin challenge
28. Modulation of anti-Thy1 nephritis in the rat by adenine nucleotides: Evidence for an anti-inflammatory role for nucleotidase
29. Pharmacological modulation of acute ocular inflammation. I. Adenosine
30. 2A activation reduces lung reperfusion injury following transplantation
31. 2A adenosine receptor inhibits inflammation in a rat model of meningitis: Synergy with type IV phosphodiesterase inhibitor, rolipram
32. A(2A) adenosine receptor-mediated inhibition of renal injury and neutrophil adhesion
33. Stimulation of angiogenesis by adenosine on the chick chorioallantoic membrane
34. Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells
35. Adenosine upregulates VEGF expression in cultured myocardial vascular smooth muscle cells
36. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells
37. Role of adenosine in the hypoxic induction of vascular endothelial growth factor in porcine brain derived microvascular endothelial cells
38. Adenosine mediates hypoxic induction of vascular endothelial growth factor in retinal pericytes and endothelial cells
39. Expression of vascular permeability factor/vascular endothelial growth factor in pig cerebral microvascular endothelial cells and its upregulation by adenosine
40. Adenosine as an endogenous mediator of hypoxia for induction of vascular endothelial growth factor mRNA
41. Positional cloning of LPS, and the general role of toll-like receptors in the innate immune response
42. A(2A) adenosine receptor deficiency attenuates brain injury induced by transient focal ischemia in mice
43. Disruption of the A(3) adenosine receptor gene in mice and its effect on stimulated inflammatory cells
44. 2A receptors in human monocytic THP-1 cells
45. Lipopolysaccharide recognition, CD14, and lipopolysaccharide receptors
46. Recognition and plasma clearance of endotoxin by scavenger receptors
47. Role for L-selectin in lipopolysaccharide-induced activation of neutrophils
48. Molecular mechanisms of vasculogenesis and embryonic angiogenesis
49. Expression of vascular permeability factor (vascular endothelial growth factor) by epidermal keratinocytes during wound healing
50. Differential immunolocalization of VEGF in rat and human adult lung, and in experimental rat lung fibrosis. Light, fluorescence, and electron microscopy
51. Vascular permeability factor/endothelial growth factor (VPF/VEGF): Accumulation and expression in human synovial fluids and rheumatoid synovial tissue
52. The role of vascular endothelial growth factor in pathological angiogenesis
53. Chloromethyl ketones block induction of nitric oxide synthase in murine macrophages by preventing activation of nuclear factor-kappa B
54. Glioblastoma growth inhibited in vivo by a dominant-negative Flk-1 mutant
55. Transcriptional regulation of the rat vascular endothelial growth factor gene by hypoxia
56. Hypoxia regulates vascular endothelial growth factor gene expression in endothelial cells identification of a 5′ enhancer
57. HIF-1: Mediator of physiological and pathophysiological responses to hypoxia
58. Induction of vascular endothelial growth factor by nitric oxide in human glioblastoma and hepatocellular carcinoma cells
59. Hypoxia response element of the human vascular endothelial growth factor gene mediates transcriptional regulation by nitric oxide: Control of hypoxia-inducible factor-1 activity by nitric oxide
60. Nitric oxide triggers enhanced induction of vascular endothelial growth factor expression in cultured keratinocytes (HaCaT) and during cutaneous wound repair
61. Neutrophil-epithelial crosstalk at the intestinal lumenal surface mediated by reciprocal secretion of adenosine and IL-6
62. 2 (G alpha s-linked) receptors
63. 2A adenosine receptor activation in PC12 pheochromocytoma cells
64. Regulation of vascular endothelial growth factor expression by cAMP in rat aortic smooth muscle cells
65. Identification of interferon-gamma as the lymphokine that activates human macrophage oxidative metabolism and antimicrobial activity
66. Development and distribution of mononuclear phagocytes